Vistagen Therapeutics, Inc. Common Stock (VTGN) is a publicly traded Healthcare sector company. As of May 21, 2026, VTGN trades at $0.62 with a market cap of $23.59M and a P/E ratio of -0.38. VTGN moved +1.22% today. Year to date, VTGN is -11.14%; over the trailing twelve months it is -75.67%. Its 52-week range spans $0.43 to $5.14. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces VTGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Vistagen Therapeutics, Inc. Common Stock (VTGN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. VTGN moved +1.22% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $0.62 |
| Market Cap | $23.59M |
| P/E Ratio | -0.38 |
| EPS | $-1.67 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.14 |
| 52-Week Low | $0.43 |
| Volume | 820 |
| Avg Volume | 0 |
| Revenue (TTM) | $486.00K |
| Net Income | $-51.42M |
| Gross Margin | 0.00% |
1 analysts cover VTGN: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.